ELISA assays showed that the injection of tRF‐1020 mimics alleviated diabetes‐induced retinal inflammation as shown by decreased expression of VEGF, interleukin (IL)‐2, and TNF‐α (Figure 3F–H). This evidence concerns the gene VEGFA and diabetes mellitus.